NEW NFCR-Supported Technology is Ready for Clinical Use With a better understanding of the genetic changes in cancer cells, and a more effective way to capture them, oncologists and scientists can be alerted to drug resistance and metastasis —allowing them to more quickly select new drugs or better therapies for…...
2019 Salisbury Award Winners
Johns Hopkins researchers Emily Han-Chung Hsiue, M.D., and Jacqueline Douglass in the Vogelstein/Kinzler Lab at the Sidney Kimmel Comprehensive Cancer Center have been researching MANAbodies, an entirely novel immunotherapeutic approach which could be a significant weapon against cancer and source of hope for patients. MANAbodies are bispecific antibodies that target…...
Strategic Media Partner
